UK and certain European countries lose WHO’s measles-free status
The UK is one of several European countries to lose its status as measles-free amid a diminishing uptake of the…
All articles by Robert Barrie
Robert Barrie
Robert Barrie is a news and features reporter for Pharmaceutical Technology. He holds a BSc in Neuroscience and his interests include infectious diseases, weight loss therapies, and health politics. Contact Rob
-
-
UK biotechs suffered restricted financing in 2025
Both the amount of equity financing and venture capital attracted by UK biotechs dropped in 2025, compounding concerns for the…
-
MSD ends takeover talks with Revolution Medicines
Merck & Co (MSD) is no longer in talks to acquire oncology biotech Revolution Medicines after negotiations hit a stumbling…
-
Corxel raises $287m as obesity continues to spark investor interest
Corxel Pharmaceuticals has raised $287m to fund its suite of cardiometabolic assets, signifying that investor appetite for weight loss drug…
-
US set to officially exit WHO in culmination of Trump’s domestic push
The US is poised to leave the World Health Organization (WHO) as the one-year countdown of legal notice comes to…
-
Davos26: Trump says tariff threats helped fix US drug pricing ‘unfairness’
The threat of tariffs was necessary to get major drugmakers and foreign leaders on board with drug pricing reforms in…
-
Walking the pharma supply chain tightrope requires more than precision
Between 2023 and 2025, hundreds of thousands of Type 2 diabetes patients were unable to access semaglutide due to off-label…
-
Shionogi expands ViiV Healthcare stake by $2.13bn as Pfizer sells up
As Pfizer sells its stake in ViiV Healthcare, Japan-based Shionogi & Co will increase its hold in the human immunodeficiency…
-
UK’s pharma outlook buoyed by trans-Atlantic trade policies
Recent policy agreements with the US may create a favourable outlook for the UK’s pharma landscape, despite recent concerns about…
-
Compounder sues Lilly and Novo for suppressing GLP-1RA competition
An American compounding pharmacy has sued Eli Lilly and Novo Nordisk for allegedly stifling patient access to compounded weight loss…